About Us


Orphanos, a division of Trial Runners LLC, is a rare disease CRO dedicated to clinical research in this rapidly growing market.
Orphanos’ unique study management solutions are tailored for the needs clients investing in cures for rare disease indications and for those patients seeking treatment options. As a global CRO, our clinical operations group focuses on specialized patient recruitment solutions to meet your needs. Orphanos applies lessons learned to feasibility assessments, recruitment and retention solutions, and logistic management in order to execute the most efficient clinical study.
Orphanos is borne of Trial Runners; a specialized niche Ophthalmology CRO; which has over 10 years of clinical trial management experience. Much of our experience is in rare ophthalmology diseases and the therapies designated as orphan drugs. Our track record of success led to repeat business with clients expanding their development programs outside of Ophthalmology and into other rare disease indications.
Let our success be your success.


We have reached new levels of management, execution, and customer service in order to bring hope to those suffering from rare diseases.


To make a difference in the area of rare diseases research and help patients with a team tailor made to match and exceed the needs of your clinical trial.


Why Orphanos? Niche expertise, quality, adaptability, and timelines.